Clinical Trial Update: Sensitivity to Intravenous Nicotine: Genetic Moderators [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update from Yale University examining how genetic factors modulate sensitivity to intravenous nicotine in individuals with nicotine dep…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence

Drugs mentioned

• Nicotine (nicotine)

Snippet

Sponsor: Yale University | Conditions: Nicotine Dependence | Phase 1 | Status: COMPLETED